Worldwide government purchasing is estimated to be over $10 Trillion each year. Of this amount a growing percentage of government contracts are for public health care, medical equipment, and drug contracts. Because of the vast amounts of money governments are spending on drug contracts, medical equipment contracts, and other procurement contracts, several large corporations have targeted these contracts and are using illegal bribes, kickbacks, fraud, and other illegal actions to secure these contracts.
As such, several governments have created reward laws called bounty actions that provide large financial incentives to persons with original knowledge of these crimes to confidentially and properly expose these crimes. By working through an international bounty action lawyer, these people include many professionals can protect their identity and career, while exposing fraud and illegal conduct.
If you are aware of a drug contract, medical equipment contract, or other government procurement contract that is the product of fraud, an illegal bribery scheme, illegal kickback scheme, and other illicit payment scheme, it is important that you properly report the government corruption and work with an international bounty action lawyer to determine the best way to expose the corruption.
To help determine if a large government corruption scheme may be a Foreign Corrupt Practices Act Whistleblower Reward Lawsuit, please feel free to send an e-mail message to International Drug Company Fraud Bounty Action Lawyer Jason Coomer.
For more information on these issues, please feel free to go to the following web pages:
Procurement Fraud International Bounty Action Lawyer
GlaxoSmithKline Agrees to Pay $3 Billion in Fraud Settlement - NYTimes.com
"In the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants for unapproved uses and failing to report safety data about a top diabetes drug, federal prosecutors announced Monday. The agreement also includes civil penalties for improper marketing of a half-dozen other drugs."